Literature DB >> 8222450

Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker.

J M Morgan1, W C Biehl, F W Wagner.   

Abstract

A recently designed Charcot Restraint Orthotic Walker (CROW) was used in the treatment of 18 patients with diabetic neuroarthropathy involving the foot and ankle. Eight of these patients had no surgery before the use of the CROW. In ten patients, the device was used for prolonged immobilization after surgery for complications of neuropathic joint disease. The CROW is a rigid, custom, full-foot enclosure ankle-foot orthosis. It was used after an initial period of cast immobilization. The CROW effectively controls limb edema, returns the patient to ambulatory activities, and prevents significant progression of deformity. All patients rated their satisfaction with the device as good or excellent. The CROW is an attractive alternative to currently used methods to provide the prolonged immobilization and protection necessary for healing in neuropathic arthropathy.

Entities:  

Mesh:

Year:  1993        PMID: 8222450

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Immobilization-induced osteolysis and recovery in neuropathic foot impairments.

Authors:  David R Sinacore; Mary K Hastings; Kathryn L Bohnert; Michael J Strube; David J Gutekunst; Jeffrey E Johnson
Journal:  Bone       Date:  2017-09-20       Impact factor: 4.398

2.  Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy.

Authors:  Mary K Hastings; David R Sinacore; Faye A Fielder; Jeffrey E Johnson
Journal:  Phys Ther       Date:  2005-03

Review 3.  Update on Charcot neuroarthropathy.

Authors:  E B Jude; A J Boulton
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

4.  Clustering and classification of regional peak plantar pressures of diabetic feet.

Authors:  Craig J Bennetts; Tammy M Owings; Ahmet Erdemir; Georgeanne Botek; Peter R Cavanagh
Journal:  J Biomech       Date:  2012-10-22       Impact factor: 2.712

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.